SCHEMBL6505060

SCHEMBL6505060

CC(C)c1ccc(Nc2nnc(Cl)c3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.57
KDR P35968 5/20 0.53
FLT1 P17948 3/20 0.53
GOT1 P17174 1/20 0.51
SMN1; SMN2 Q16637 5/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.48
NFKB1 P19838 1/20 0.45
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
POLB P06746 2/20 0.43
HTR2A P28223 1/20 0.43
GAA P10253 1/20 0.43
TNKS O95271 1/20 0.43
CIT O14578 1/20 0.43
EGFR P00533 1/20 0.43
HLA-A P04439 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496240 0.83 KDR (0.58) KDRFLT1GOT1SMN1; SMN2ALDH1A1
SCHEMBL10338919 0.83 GOT1 (0.61) MAPTKDRFLT1GOT1SMN1; SMN2
Hydrochloric Acid SCHEMBL6502127 0.82 KDR (0.57) KDRFLT1GOT1SMN1; SMN2ALDH1A1
SCHEMBL3759288 0.80 KDR (0.63) MAPTKDRSMN1; SMN2ALDH1A1RAB9A
SCHEMBL3764417 0.74 SHMT2 (0.60) MAPTKDRFLT1POLBGAA
Hydrochloric Acid SCHEMBL6608902 0.74 KDR (0.74) KDRFLT1CITEGFRHLA-A
SCHEMBL2200375 0.74 MAPT (0.50) MAPTKDRFLT1EGFRCSF1R
SCHEMBL28961841 0.73 GOT1 (0.53) MAPTGOT1SMN1; SMN2ALDH1A1HPGD
SCHEMBL28961875 0.73 GOT1 (0.53) MAPTGOT1SMN1; SMN2ALDH1A1HPGD
SCHEMBL28961838 0.73 GOT1 (0.53) MAPTGOT1SMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903101-B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity BAYER PHARMACEUTICALS CORPORATION (US) 2005-06-07 US disclosed
EP-1208096-B1 SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY BAYER AG (US) 2004-04-28 EP disclosed
CN-1378543-A Substituted pyridazines and fused pyridazines having angiogenesis inhibiting activity BAYER AG (US) 2002-11-06 CN disclosed
EP-1208096-A1 SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY Bayer Corporation (US) 2002-05-29 EP disclosed
WO-2001010859-A1 SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY BAYER CORPORATION (US) 2001-02-15 WO disclosed